[68Ga]Ga-PSMA-617 PET/MRI for imaging patients suspected of hepatocellular carcinoma
European Journal of Nuclear Medicine and Molecular Imaging · 2025-03 · 52 (4) · 1278-1290
DOI: 10.1007/s00259-024-06973-7 ↗Kurz gefasst
Klinische Studie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 21.11.2024. Verfasst von Chunxia Qin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei Province,…. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Magnetic Resonance Imaging, Heterocyclic Compounds, 1-Ring. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hubei Province Science and Technology Innovation Team, Key Project of Hubei Province Natural Science Foundation.
Abstract (Originalsprache)
PURPOSE: Radiolabeled probes targeting prostate-specific membrane antigen (PSMA) have been used in prostate cancer. Moreover, PSMA is also overexpressed on neovessels in hepatocellular carcinoma (HCC). This study aimed to preliminarily evaluate the diagnostic effectiveness of [68Ga]Ga-PSMA-617 PET/MRI for HCC. METHODS: Patients suspected of HCC were prospectively enrolled in this single-center study (NCT05006326, 2021-08-16) to perform [68Ga]Ga-PSMA-617 PET/MRI, along with contrast enhanced CT (ceCT) or ceMRI. The main suspicious intrahepatic lesions were resected and pathologically verified. Visual evaluation of [68Ga]Ga-PSMA-617 PET/MRI images was performed on all lesions. Maximum standard uptake value (SUVmax), mean standard uptake value (SUVmean), tumor-to-liver ratio (TLR), tumor-to-blood ratio (TBR), and tumor-to-parotid ratio (TPR) were measured or calculated. The diagnostic efficiency of different modalities was summarized. PSMA expression was evaluated by immunohistochemistry and the correlation of PSMA expression and [68Ga]Ga-PSMA-617 uptake in HCC primary tumors was quantitatively analyzed. RESULTS: A total of 12 patients (ten men and two women; mean age 58.75 ± 12.08 years) were included. Ten patients were diagnosed with HCC, 2 with intrahepatic cholangiocarcinoma (ICC), and 4 with hemangioma. The SUVmax, TLR, TBR, and TPR of HCC primary tumors were higher than those of ICC and hemangioma. The diagnostic accuracy of [68Ga]Ga-PSMA-617 PET/MRI for primary HCC was 82.4%. When combined with ceCT or ceMRI, the accuracy increased to 88.2%. A moderate correlation was observed between SUVmax and mean PSMA expression in HCC primary tumors (R = 0.788). CONCLUSION: Utilizing a hybrid PET/MRI system to combine [68Ga]Ga-PSMA-617 PET/MRI with ceMRI is a promising one-stop solution for the accurate diagnosis of HCC. TRIAL REGISTRATION: NCT05006326. Registered August 16, 2021, https://clinicaltrials.gov/study/NCT05006326 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei Province, China.
- Hubei Province Key Laboratory of Molecular Imaging, Wuhan, 430022, Hubei Province, China.
- Key Laboratory of Biological Targeted Therapy, the Ministry of Education, Wuhan, 430022, Hubei Province, China.
- Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei Province, China.
- Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei Province, China.
- Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei Province, China. wanchidan@hust.edu.cn.
ORCID-Profile: Xiaoli Lan
Förderung
- National Natural Science Foundation of China
- Hubei Province Science and Technology Innovation Team
- Key Project of Hubei Province Natural Science Foundation
Zitieren
APA
Qin, C., Song, X., Sun, S., Song, Y., Ruan, W., Gai, Y., Yang, M., Wan, C., & Lan, X. (2025). [68Ga]Ga-PSMA-617 PET/MRI for imaging patients suspected of hepatocellular carcinoma. European Journal of Nuclear Medicine and Molecular Imaging, 52(4), 1278-1290. https://doi.org/10.1007/s00259-024-06973-7
Vancouver
Qin C, Song X, Sun S, Song Y, Ruan W, Gai Y, et al. [68Ga]Ga-PSMA-617 PET/MRI for imaging patients suspected of hepatocellular carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 2025;52(4):1278-1290. doi:10.1007/s00259-024-06973-7
BibTeX
@article{Qin2025,
author = {Qin, Chunxia and Song, Xiangming and Sun, Shiran and Song, Yangmeihui and Ruan, Weiwei and Gai, Yongkang and Yang, Ming and Wan, Chidan and Lan, Xiaoli},
title = {[68Ga]Ga-PSMA-617 PET/MRI for imaging patients suspected of hepatocellular carcinoma},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2025},
volume = {52},
number = {4},
pages = {1278--1290},
doi = {10.1007/s00259-024-06973-7}
}
EUVIMED